At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportWhen Karen was diagnosed with ovarian cancer in 2008, Biologics by McKesson was there to help put her mind at ease.
Watch time: 3 minutes
Love this story? View more Biologics patient experiences at biologics.mckesson.com.
Originally published October 2021
Since the time of publication, Ashleigh Burdette has left the business.
At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How community oncology clinics are helping break down barriers to care.
How community oncology clinics are helping break down barriers to care.
How Sarah Cannon Research Institute’s clinical trials changed Mike’s cancer journey.
How Sarah Cannon Research Institute’s clinical trials changed Mike’s cancer journey.
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
In the fourth episode of our Always Advancing video series, discover how InspiroGene by McKesson partners with biopharma to expand patient access to advanced therapies.
In the fourth episode of our Always Advancing video series, discover how InspiroGene by McKesson partners with biopharma to expand patient access to advanced therapies.
Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.
Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.
In the second episode of our Always Advancing series, we explore how McKesson and biopharma are breaking barriers to accelerate access to lifesaving therapies.
In the second episode of our Always Advancing series, we explore how McKesson and biopharma are breaking barriers to accelerate access to lifesaving therapies.